Clinical Data Presented at 2022 North American Neuromodulati

/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...

Related Keywords

California , United States , Idaho , Redwood City , Erika Petersen , Julie Dewey , D Keith Grossman , Jessica Jameson , Leonardo Kapural , Instagram , Linkedin , Twitter , Axis Spine Center , American Neuromodulation Society , Nevro Corp , Exchange Commission , Us Food Drug Administration , Facebook , Corp Communications , University Of Arkansas , Annual Meeting , Diabetic Neuropathy , Surgical Refractory Back Pain , Principal Investigators , Painful Diabetic Neuropathy , Principal Investigator , Restorative Neurosurgery , Medical Sciences , Treating Non Surgical Refractory Back Pain , Conventional Medical Management , P Value Cost Effectiveness , Non Surgical Refractory Back Pain , Premarket Approval , Senza Omnia , Month Multicenter Randomized Controlled Trial , North American Neuromodulation Society , Treating Non Surgical Refractory Back , Non Surgical Refractory Back , Private Securities Litigation Reform Act , Quarterly Report , Investor Relations ,